Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 17:2022:5142918.
doi: 10.1155/2022/5142918. eCollection 2022.

Continuous Glucose Monitoring for the Diagnosis of Gestational Diabetes Mellitus: A Pilot Study

Daria Di Filippo  1 , Marrwah Ahmadzai  1 , Melissa Han Yiin Chang  1 , Ksana Horgan  1 , Ru Min Ong  1 , Justine Darling  2 , Mahmood Akhtar  1 , Amanda Henry  1 , Alec Welsh  1   3
Affiliations

Continuous Glucose Monitoring for the Diagnosis of Gestational Diabetes Mellitus: A Pilot Study

Daria Di Filippo et al. J Diabetes Res. .

Abstract

Background: Gestational diabetes mellitus (GDM) is diabetes first diagnosed in pregnancy. GDM, together with its short- and long-term negative outcomes, is increasing in incidence all over the world. The current diagnostic method for GDM, the oral glucose tolerance test (OGTT), is dated and has been reported as inconvenient for women as well as poorly reproducible and reliable.

Aims: We aimed at assessing the acceptability, feasibility, and accuracy of continuous glucose monitoring (CGM) as a diagnostic test for GDM and explore its correlation with the OGTT and risk factors for GDM.

Methods: In this prospective cohort study, pregnant women due for or having completed OGTT underwent CGM for seven days, performing daily finger-prick blood glucose levels before completing an acceptability questionnaire. Data on GDM risk factors and CGM variability were analyzed and compared with OGTT results.

Results: Seventy-three women completed CGM (40 GDM, 33 normal glucose tolerances); 34 concurrently underwent OGTT. CGM was acceptable and generally well-tolerated, with skin irritation/itchiness the only adverse event (11 mild, one severe). CGM and OGTT strongly correlated for fasting glucose values (r = 0.86, p < 0.05) only. Triangulating GDM risk factors, OGTT results and CGM variability parameters with the application of machine learning highlighted the possibility of unmasking false positive (11 showed low CGM variability and demographic risks but positive OGTT) and false-negative OGTT diagnoses (1 showed high CGM variability and demographic risks but negative OGTT).

Conclusions: CGM was well-tolerated, showing poorer glycaemic control in GDM, and revealing potential misdiagnosis of the OGTT when combined with GDM risk factors. Future research is needed to determine cut-off values for CGM-defined and OGTT-independent screening criteria for GDM.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Consort diagram.
Figure 2
Figure 2
Results of CDRFS, OGTT results, and CGMSV triangulation.
See this image and copyright information in PMC

References

    1. Group HSCR. The hyperglycemia and adverse pregnancy outcome (HAPO) study. International Journal of Gynaecology and Obstetrics . 2002;78(1):69–77. doi: 10.1016/S0020-7292(02)00092-9. - DOI - PubMed
    1. Plows J. F., Stanley J. L., Baker P. N., Reynolds C. M., Vickers M. H. The pathophysiology of gestational diabetes mellitus. International Journal of Molecular Sciences . 2018;19(11):p. 3342. doi: 10.3390/ijms19113342. - DOI - PMC - PubMed
    1. Guariguata L., Linnenkamp U., Beagley J., Whiting D. R., Cho N. H. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Research and Clinical Practice . 2014;103(2):176–185. doi: 10.1016/j.diabres.2013.11.003. - DOI - PubMed
    1. Group HSCR, Metzger B. E., Lowe L. P., Dyer A. R., Trimble E. R., Chaovarindr U., et al. Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine . 2008;358(19):1991–2002. doi: 10.1056/NEJMoa0707943. - DOI - PubMed
    1. Tieu J., McPhee A. J., Crowther C. A., Middleton P. Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database of Systematic Reviews . 2014;2:p. CD007222. doi: 10.1002/14651858.CD007222.pub3. - DOI - PubMed

LinkOut - more resources